7. Humpel C, Weis C. Nerve growth factor and cholinergic CNS 27.
neurons studied in organotypic brain slices. Implication in Alzheimer's disease? J Neural Transm Suppl 2002:253–263.
8. Hatanaka H, Nihonmatsu I, Tsukui H. Nerve growth factor 28.
promotes survival of cultured magnocellular cholinergic neurons
from nucleus basalis of Meynert in postnatal rats. Neurosci Lett
1988;90:63– 68.
9. Burgos I, Cuello AC, Liberini P, et al. NGF-mediated synaptic 29.
sprouting in the cerebral cortex of lesioned primate brain. Brain
Res 1995;692:154 –160.
10. Lad SP, Neet KE, Mufson EJ. Nerve growth factor: structure, 30.
function and therapeutic implications for Alzheimer's disease.
Curr Drug Target CNS Neurol Disord 2003;2:315–334.
11. Kaplan DR, Miller FD. Signal transduction by the neurotro- 31.
phin receptors. Curr Opin Cell Biol 1997;9:213–221.
12. Sobreviela T, Clary DO, Reichardt LF, et al. TrkAimmunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor recep- 32.
tor, choline acetyltransferase, and serotonin. J Comp Neurol
1994;350:587– 611.
13. Chao MV, Bothwell MA, Ross AH, et al. Gene transfer and
33.
molecular cloning of the human NGF receptor. Science 1986;
232:518 –521.
14. Mahadeo D, Kaplan L, Chao MV, Hempstead BL. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit
34.
polypeptide receptors. J Biol Chem 1994;269:6884 – 6891.
15. Roux PP, Barker PA. Neurotrophin signaling through the p75
neurotrophin receptor. Prog Neurobiol 2002;67:203–233.
35.
16. Hempstead BL, Martin-Zanca D, Kaplan DR, et al. Highaffinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 1991;350:
36.
678 – 683.
17. Delcroix JD, Valletta JS, Wu C, et al. NGF signaling in sensory
neurons: evidence that early endosomes carry NGF retrograde
37.
signals. Neuron 2003;39:69 – 84.
18. Grimes ML, Zhou J, Beattie EC, et al. Endocytosis of activated
TrkA: evidence that nerve growth factor induces formation of
38.
signaling endosomes. J Neurosci 1996;16:7950 –7964
19. Ye H, Kuruvilla R, Zweifel LS, Ginty DD. Evidence in support
of signaling endosome-based retrograde survival of sympathetic
39.
neurons. Neuron 2003;39:57– 68.
20. Klesse LJ, Parada LF. Trks: signal transduction and intracellular
pathways. Microsc Res Tech 1999;45:210 –216.
21. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor
40.
signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217–1281. 41.
22. Mufson EJ, Ma SY, Dills J, et al. Loss of basal forebrain
P75(NTR) immunoreactivity in subjects with mild cognitive
impairment and Alzheimer's disease. J Comp Neurol 2002;443:
136 –153.
23. Mufson EJ, Ma SY, Cochran EJ, et al. Loss of nucleus basalis 42.
neurons containing trkA immunoreactivity in individuals with
mild cognitive impairment and early Alzheimer's disease.
J Comp Neurol 2000;427:19 –30. 43.
24. Gilmor ML, Erickson JD, Varoqui H, et al. Preservation of
nucleus basalis neurons containing choline acetyltransferase and
the vesicular acetylcholine transporter in the elderly with mild 44.
cognitive impairment and early Alzheimer's disease. J Comp
Neurol 1999;411:693–704.
25. Hock C, Heese K, Muller-Spahn F, et al. Decreased trkA neu- 45.
rotrophin receptor expression in the parietal cortex of patients
with Alzheimer's disease. Neurosci Lett 1998;241:151–154.
26. Mufson EJ, Lavine N, Jaffar S, et al. Reduction in p140-TrkA 46.
receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 1997;146:91–103.
